154 related articles for article (PubMed ID: 37814370)
1. Cancer Cell Membrane-Based Materials for Biomedical Applications.
Lu Y; Fan L; Wang J; Hu M; Wei B; Shi P; Li J; Feng J; Zheng Y
Small; 2024 Feb; 20(7):e2306540. PubMed ID: 37814370
[TBL] [Abstract][Full Text] [Related]
2. Targeting drugs to tumours using cell membrane-coated nanoparticles.
Fang RH; Gao W; Zhang L
Nat Rev Clin Oncol; 2023 Jan; 20(1):33-48. PubMed ID: 36307534
[TBL] [Abstract][Full Text] [Related]
3. Cell membrane camouflaged bismuth nanoparticles for targeted photothermal therapy of homotypic tumors.
Ren X; Yang S; Yu N; Sharjeel A; Jiang Q; Macharia DK; Yan H; Lu C; Geng P; Chen Z
J Colloid Interface Sci; 2021 Jun; 591():229-238. PubMed ID: 33609894
[TBL] [Abstract][Full Text] [Related]
4. Microfluidic Sonication To Assemble Exosome Membrane-Coated Nanoparticles for Immune Evasion-Mediated Targeting.
Liu C; Zhang W; Li Y; Chang J; Tian F; Zhao F; Ma Y; Sun J
Nano Lett; 2019 Nov; 19(11):7836-7844. PubMed ID: 31597431
[TBL] [Abstract][Full Text] [Related]
5. Cancer Cell Membrane-Coated Gambogic Acid Nanoparticles for Effective Anticancer Vaccination by Activating Dendritic Cells.
Huang F; Zhang Q; Xiao J; Zhang X; Han X; Shi X; Hu J; Li L; Qian X
Int J Nanomedicine; 2023; 18():2261-2273. PubMed ID: 37159807
[TBL] [Abstract][Full Text] [Related]
6. Cancer cell membrane-coated nanoparticles: a promising anti-tumor bionic platform.
Guo Q; Wang S; Xu R; Tang Y; Xia X
RSC Adv; 2024 Mar; 14(15):10608-10637. PubMed ID: 38567339
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of cancer-cell-membrane-camouflaged hemoporfin-Cu
Zhao Y; Wen M; Yu N; Tao C; Ren Q; Qiu P; Zhang Y; Wang Y; Xia J; Chen Z
J Colloid Interface Sci; 2023 May; 637():225-236. PubMed ID: 36701868
[TBL] [Abstract][Full Text] [Related]
8. Advancements in cell membrane camouflaged nanoparticles: A bioinspired platform for cancer therapy.
Dhas N; García MC; Kudarha R; Pandey A; Nikam AN; Gopalan D; Fernandes G; Soman S; Kulkarni S; Seetharam RN; Tiwari R; Wairkar S; Pardeshi C; Mutalik S
J Control Release; 2022 Jun; 346():71-97. PubMed ID: 35439581
[TBL] [Abstract][Full Text] [Related]
9. Cancer-Cell-Membrane-Coated Nanoparticles with a Yolk-Shell Structure Augment Cancer Chemotherapy.
Nie D; Dai Z; Li J; Yang Y; Xi Z; Wang J; Zhang W; Qian K; Guo S; Zhu C; Wang R; Li Y; Yu M; Zhang X; Shi X; Gan Y
Nano Lett; 2020 Feb; 20(2):936-946. PubMed ID: 31671946
[TBL] [Abstract][Full Text] [Related]
10. Efficient sonodynamic ablation of deep-seated tumors via cancer-cell-membrane camouflaged biocompatible nanosonosensitizers.
Wen M; Zhao Y; Qiu P; Ren Q; Tao C; Chen Z; Yu N
J Colloid Interface Sci; 2023 Aug; 644():388-396. PubMed ID: 37120887
[TBL] [Abstract][Full Text] [Related]
11. Homotypic Targeting Delivery of siRNA with Artificial Cancer Cells.
Zhang L; Deng S; Zhang Y; Peng Q; Li H; Wang P; Fu X; Lei X; Qin A; Yu X
Adv Healthc Mater; 2020 May; 9(9):e1900772. PubMed ID: 32181988
[TBL] [Abstract][Full Text] [Related]
12. Cell membrane-coated nanoparticles: research advances.
Zou S; Wang B; Wang C; Wang Q; Zhang L
Nanomedicine (Lond); 2020 Mar; 15(6):625-641. PubMed ID: 32098564
[TBL] [Abstract][Full Text] [Related]
13. Gold nanoparticles interacting with synthetic lipid rafts: an AFM investigation.
Ridolfi A; Caselli L; Montis C; Mangiapia G; Berti D; Brucale M; Valle F
J Microsc; 2020 Dec; 280(3):194-203. PubMed ID: 32432336
[TBL] [Abstract][Full Text] [Related]
14. Targeted Therapy for Hepatocellular Carcinoma: Co-Delivery of Sorafenib and Curcumin Using Lactosylated pH-Responsive Nanoparticles.
Bian Y; Guo D
Drug Des Devel Ther; 2020; 14():647-659. PubMed ID: 32109990
[TBL] [Abstract][Full Text] [Related]
15. Stem cell membrane, stem cell-derived exosomes and hybrid stem cell camouflaged nanoparticles: A promising biomimetic nanoplatforms for cancer theranostics.
Khosravi N; Pishavar E; Baradaran B; Oroojalian F; Mokhtarzadeh A
J Control Release; 2022 Aug; 348():706-722. PubMed ID: 35732250
[TBL] [Abstract][Full Text] [Related]
16. A biomimetic nanoplatform for customized photothermal therapy of HNSCC evaluated on patient-derived xenograft models.
Wu Q; Chen L; Huang X; Lin J; Gao J; Yang G; Wu Y; Wang C; Kang X; Yao Y; Wang Y; Xue M; Luan X; Chen X; Zhang Z; Sun S
Int J Oral Sci; 2023 Feb; 15(1):9. PubMed ID: 36765028
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity.
Kim TH; Jiang HH; Youn YS; Park CW; Tak KK; Lee S; Kim H; Jon S; Chen X; Lee KC
Int J Pharm; 2011 Jan; 403(1-2):285-91. PubMed ID: 21035530
[TBL] [Abstract][Full Text] [Related]
18. Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy.
Chen HY; Deng J; Wang Y; Wu CQ; Li X; Dai HW
Acta Biomater; 2020 Aug; 112():1-13. PubMed ID: 32470527
[TBL] [Abstract][Full Text] [Related]
19. Biomimetic Nanoparticles Coated with Bacterial Outer Membrane Vesicles as a New-Generation Platform for Biomedical Applications.
Naskar A; Cho H; Lee S; Kim KS
Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834302
[TBL] [Abstract][Full Text] [Related]
20. Surface modification potentials of cell membrane-based materials for targeted therapies: a chemotherapy-focused review.
Duan H; Wang L; Wang S; He Y
Nanomedicine (Lond); 2023 Aug; 18(19):1281-1303. PubMed ID: 37753724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
